Form 4 for SUPN SUPERNUS PHARMACEUTICALS, INC.
Accepted 2025-01-23 00:00:00 ET · period of report 2025-01-22 · accession 0001628280-25-002388 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-23 | 2025-01-22 | SUPN | Hudson Frederick M. | Dir | M - OptEx | $9.13 | +20.0K | 48.4K | +70% | +$182.6K |
| D | 2025-01-23 | 2025-01-22 | SUPN | Hudson Frederick M. | Dir | M - OptEx | $0.00 | -20.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-22 | M | A | 20,000 | $9.13 | 48,395 | D | — | — | |
| 2 | Derivative | Director Stock Option (Right to Buy) | 2025-01-22 | M | D | 20,000 | $0.00 | 0 | D | $9.13 · 2016-03-03 to 2025-03-03 | 20,000 Common Stock |